Bristol-Myers Squibb Scientist Recognized for Significant Contribution to Medicinal Chemistry
John E. Macor, PhD, executive director of Neuroscience Discovery Chemistry
Bristol-Myers Squibb Company congratulates John E. Macor, PhD, executive director of Neuroscience Discovery Chemistry, for his selection as a 2011 Fellow of the American Chemical Society (ACS), an honor bestowed upon a select group of distinguished scientists who have demonstrated outstanding accomplishments in chemistry and made important contributions to ACS.
Originally from New Jersey and now a resident of Guilford, CT, Macor is humbled by the recognition bestowed by his peers. “This is a wonderful honor,” he noted. “I’ve been doing this for 25 years, and every day you learn something new. There is continual learning.” Medicinal chemists play an essential role in drug discovery by evaluating a large amount of complex data to determine what molecules to create to treat a specific disease. It often takes thousands of compounds to find the one that is safe and effective.
Macor has been with Bristol-Myers Squibb for 14 years, working in the fields of neuroscience, cardiovascular disease, inflammation and oncology. Among his many accomplishments, he was a co-inventor of an anti-migraine drug and has advanced 10 compounds into human clinical trials in his career, including an investigational treatment for Alzheimer ’s disease.
“The honor is well deserved, as Dr. Macor has shown excellence in his profession, and has contributed greatly to the advancement of medicinal chemistry to develop treatments to help patients in need,” said Joel Barrish, vice president, Medicinal Chemistry, Bristol-Myers Squibb.
Macor was also honored as a Scarborough Award winner in 2009, an annual award conferred by the ACS’s Division of Medicinal Chemistry to the top medicinal chemist under the age of 50.